TCL Archive NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option April 2, 1982
TCL Archive In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership July 10, 1992
TCL Archive In Brief: CCIRC Recommends Central Oncology Group For Phasing Out; Rogers Backs Pay Raise March 5, 1976
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
